Another Epidemic in the Shadow of Covid 19 Pandemic:
A Review of Monkeypox

While humanity has not been able to end the fight against the COVID-19 pandemic, newly reported cases of monkeypox have caused unease. The current review sheds light on the transmission routes, pathogenesis, clinical presentation, treatment, and prevention of the disease in this early stage of the ongoing monkeypox epidemic.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık

1. WHO disease outbreak news. Monkeypox - United Kingdom of Great Britain and Northern Ireland. 16 May, 2022. Available at: https://www.who.int/emergencies/disease-outbreaknews/item/2022-DON381. Accessed May 21, 2022.
2. Heymann DL, Szczeniowski M, Esteves K. Re-emergence of monkeypox in Africa: a review of the past six years. Br Med Bull 1998;54:693–702. [CrossRef]
3. Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, et al. The changing epidemiology of human monkeypoxA potential threat? A systematic review. PLoS Negl Trop Dis 2022;16:e0010141. [CrossRef]
4. Angelo KM, Petersen BW, Hamer DH, Schwartz E, Brunette G. Monkeypox transmission among international travellers-serious monkey business? J Travel Med 2019;26:taz002.
5. WHO disease outbreak news. Monkeypox - United Kingdom of Great Britain and Northern Ireland. 18 May, 2022. Available at: https://www.who.int/emergencies/disease-outbreaknews/item/2022-DON383. Accessed May 21, 2022.
6. Grant R, Nguyen LL, Breban R. Modelling human-to-human transmission of monkeypox. Bull World Health Organ 2020;98:638–40. [CrossRef]
7. Damon IK. Poxviruses. Manual of Clinical Microbiology 2006;2:1631–40.
8. Nguyen PY, Ajisegiri WS, Costantino V, Chughtai AA, MacIntyre CR. Reemergence of human monkeypox and declining population immunity in the context of urbanization, Nigeria, 2017- 2020. Emerg Infect Dis 2021;27:1007–14. [CrossRef]
9. Beer EM, Rao VB. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLOS Negl Trop Dis 2019;13:e0007791. [CrossRef]
10. Petersen E, Kantele A, Koopmans M, Asogun D, Yinka-Ogunleye A, Ihekweazu C, et al. Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention. Infect Dis Clin North Am 2019;33:1027–43. [CrossRef]
11. Nalca A, Rimoin AW, Bavari S, Whitehouse CA. Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. Clin Infect Dis 2005;41:1765–71. [CrossRef]
12. Likos AM, Sammons SA, Olson VA, Frace AM, Li Y, Olsen-Rasmussen M, et al. A tale of two clades: monkeypox viruses. J Gen Virol 2005;86:2661–72. [CrossRef]
13. Stanford MM, McFadden G, Karupiah G, Chaudhri G. Immunopathogenesis of poxvirus infections: forecasting the impending storm. Immunol Cell Biol 2007;85:93–102. [CrossRef]
14. Chen N, Li G, Liszewski MK, Atkinson JP, Jahrling PB, Feng Z, et al. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology 2005;340:46– 63. [CrossRef]
15. Liszewski MK, Leung MK, Hauhart R, Buller RM, Bertram P, Wang X, et al. Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation. J Immunol 2006;176:3725–34. [CrossRef]
16. Sklenovská N, Van Ranst M. Emergence of monkeypox as the most important orthopoxvirus infection in humans. Front Public Health 2018;6:241. [CrossRef]
17. McCollum AM, Damon IK. Human monkeypox. Clin Infect Dis 2014;58:260–7. [CrossRef]
18. Reynolds MG, McCollum AM, Nguete B, Shongo Lushima R, Petersen BW. Improving the care and treatment of monkeypox patients in low-resource settings: applying evidence from contemporary biomedical and smallpox biodefense research. Viruses 2017;9:380. [CrossRef]
19. Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution. Viruses 2020;12:1257. [CrossRef]
20. Grabenstein JD, Winkenwerder W Jr. US military smallpox vaccination program experience. JAMA 2003;289:3278-82.
21. Yang G, Pevear DC, Davies MH, Collett MS, Bailey T, Rippen S, et al. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge. J Virol 2005;79:13139–49.
22. Berhanu A, Prigge JT, Silvera PM, Honeychurch KM, Hruby DE, Grosenbach DW. Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection. Antimicrob Agents Chemother 2015;59:4296–300. [CrossRef]
23. Hutson CL, Kondas AV, Mauldin MR, Doty JB, Grossi IM, Morgan CN, et al. Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model. mSphere 2021;6:e00927–20. [CrossRef]
24. Hostetler KY, Beadle JR, Trahan J, Aldern KA, Owens G, Schriewer J, et al. Oral 1-O-octadecyl-2-O-benzyl-sn-glycero3-cidofovir targets the lung and is effective against a lethal respiratory challenge with ectromelia virus in mice. Antiviral Res 2007;73:212–8. [CrossRef]
25. Xiao Y, Isaacs SN. Therapeutic vaccines and antibodies for treatment of orthopoxvirus infections. Viruses 2010;2:2381– 403. [CrossRef]
26. WHO. Monkeypox- United Kingdom of Great Britain and Northern-Ireland. Available at: https://www.who.int/emergencies/disease-outbreaknews/item/monkeypox. Accessed May 5, 2022.
27. Reynolds MG, Doty JB, McCollum AM, Olson VA, Nakazawa Y. Monkeypox re-emergence in Africa: a call to expand the concept and practice of One Health. Expert Rev Anti Infect Ther 2019;17:129–39. [CrossRef]
28. Sarwar S, Maskey U, Thada PK, Mustansir M, Sarfraz A, Sarfraz Z. Re-emergence of monkeypox amidst delta variant concerns: A point of contention for public health virology? J Med Virol. 2021 Aug 28. doi: 10.1002/jmv.27306. [Epub ahead of print].
29. CDC. Monkeypox prevention. Available at: https:// www.cdc.gov/poxvirus/monkeypox/prevention. html#:~:text=Avoid%20contact%20with%20animals%20 that,be%20at%20risk%20for%20infection. Accessed May 21, 2022.
30. Hutin YJ, Williams RJ, Malfait P, Pebody R, Loparev VN, Ropp SL, et al. Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis 2001;7:434–8. [CrossRef]

APA	Okyay R, kaya e, Bayrak E, Şahin A, Koçyiğit B, TAŞDOĞAN A, Avci A, Sumbul H (2022). Another Epidemic in the Shadow of Covid 19 Pandemic: A Review of Monkeypox. , 95 - 99. 10.14744/ejmo.2022.2022
Chicago	Okyay Ramazan Azim,kaya erhan,Bayrak Edip,Şahin Ahmet Rıza,Koçyiğit Burhan Fatih,TAŞDOĞAN Ali Muhittin,Avci Akkan,Sumbul Hilmi Erdem Another Epidemic in the Shadow of Covid 19 Pandemic: A Review of Monkeypox. (2022): 95 - 99. 10.14744/ejmo.2022.2022
MLA	Okyay Ramazan Azim,kaya erhan,Bayrak Edip,Şahin Ahmet Rıza,Koçyiğit Burhan Fatih,TAŞDOĞAN Ali Muhittin,Avci Akkan,Sumbul Hilmi Erdem Another Epidemic in the Shadow of Covid 19 Pandemic: A Review of Monkeypox. , 2022, ss.95 - 99. 10.14744/ejmo.2022.2022
AMA	Okyay R,kaya e,Bayrak E,Şahin A,Koçyiğit B,TAŞDOĞAN A,Avci A,Sumbul H Another Epidemic in the Shadow of Covid 19 Pandemic: A Review of Monkeypox. . 2022; 95 - 99. 10.14744/ejmo.2022.2022
Vancouver	Okyay R,kaya e,Bayrak E,Şahin A,Koçyiğit B,TAŞDOĞAN A,Avci A,Sumbul H Another Epidemic in the Shadow of Covid 19 Pandemic: A Review of Monkeypox. . 2022; 95 - 99. 10.14744/ejmo.2022.2022
IEEE	Okyay R,kaya e,Bayrak E,Şahin A,Koçyiğit B,TAŞDOĞAN A,Avci A,Sumbul H "Another Epidemic in the Shadow of Covid 19 Pandemic: A Review of Monkeypox." , ss.95 - 99, 2022. 10.14744/ejmo.2022.2022
ISNAD	Okyay, Ramazan Azim vd. "Another Epidemic in the Shadow of Covid 19 Pandemic: A Review of Monkeypox". (2022), 95-99. https://doi.org/10.14744/ejmo.2022.2022

APA	Okyay R, kaya e, Bayrak E, Şahin A, Koçyiğit B, TAŞDOĞAN A, Avci A, Sumbul H (2022). Another Epidemic in the Shadow of Covid 19 Pandemic: A Review of Monkeypox. Eurasian Journal of Medicine and Oncology, 6(2), 95 - 99. 10.14744/ejmo.2022.2022
Chicago	Okyay Ramazan Azim,kaya erhan,Bayrak Edip,Şahin Ahmet Rıza,Koçyiğit Burhan Fatih,TAŞDOĞAN Ali Muhittin,Avci Akkan,Sumbul Hilmi Erdem Another Epidemic in the Shadow of Covid 19 Pandemic: A Review of Monkeypox. Eurasian Journal of Medicine and Oncology 6, no.2 (2022): 95 - 99. 10.14744/ejmo.2022.2022
MLA	Okyay Ramazan Azim,kaya erhan,Bayrak Edip,Şahin Ahmet Rıza,Koçyiğit Burhan Fatih,TAŞDOĞAN Ali Muhittin,Avci Akkan,Sumbul Hilmi Erdem Another Epidemic in the Shadow of Covid 19 Pandemic: A Review of Monkeypox. Eurasian Journal of Medicine and Oncology, vol.6, no.2, 2022, ss.95 - 99. 10.14744/ejmo.2022.2022
AMA	Okyay R,kaya e,Bayrak E,Şahin A,Koçyiğit B,TAŞDOĞAN A,Avci A,Sumbul H Another Epidemic in the Shadow of Covid 19 Pandemic: A Review of Monkeypox. Eurasian Journal of Medicine and Oncology. 2022; 6(2): 95 - 99. 10.14744/ejmo.2022.2022
Vancouver	Okyay R,kaya e,Bayrak E,Şahin A,Koçyiğit B,TAŞDOĞAN A,Avci A,Sumbul H Another Epidemic in the Shadow of Covid 19 Pandemic: A Review of Monkeypox. Eurasian Journal of Medicine and Oncology. 2022; 6(2): 95 - 99. 10.14744/ejmo.2022.2022
IEEE	Okyay R,kaya e,Bayrak E,Şahin A,Koçyiğit B,TAŞDOĞAN A,Avci A,Sumbul H "Another Epidemic in the Shadow of Covid 19 Pandemic: A Review of Monkeypox." Eurasian Journal of Medicine and Oncology, 6, ss.95 - 99, 2022. 10.14744/ejmo.2022.2022
ISNAD	Okyay, Ramazan Azim vd. "Another Epidemic in the Shadow of Covid 19 Pandemic: A Review of Monkeypox". Eurasian Journal of Medicine and Oncology 6/2 (2022), 95-99. https://doi.org/10.14744/ejmo.2022.2022